4 March 2024 - Wezlana is the first biosimilar to Stelera to be available for Canadian patients in all indications.

Amgen Canada today announced that Wezlana (ustekinumab injection) and Wezlana IV (ustekinumab for injection, solution for intravenous infusion), a biosimilar to Stelara, is now available in Canada.